Applied DNA Sciences Inc (APDN)

[TheyCallMeBruce]

This could explain the new CFO change.

From 10K/A

!> We concluded that our disclosure controls and procedures were not
!> effective as of September 30, 2013 and this deficiency constituted a
!> material weakness in our internal control over financial reporting as of
!> September 30, 2013. The material weakness, which arose primarily due to
!> the need for more enhanced and formalized documentation and procedures
!> regarding the financial statement closing and review process, is further
!> described in Item 9A of this Annual Report on Form 10-K. We are taking
!> the following steps to remediate this material weakness and to improve
!> our disclosure controls and procedures:
!>
!> · Our CEO has appointed a Sarbanes-Oxley project leadership team,
!> consisting of our CFO and our Controller, that will oversee the project;
!>
!> · Together with a consultant that we have engaged, we have enhanced
!> our review procedures and the documentation thereof; and
!>
!> · We are prepared to implement these enhanced procedures as we are
!> preparing our Form 10-Q for the period ended March 31, 2014.
!>